Homocysteine levels, genetic background, and cognitive impairment in Parkinson’s disease

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1432-1459
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Homocysteine levels, genetic background, and cognitive impairment in Parkinson’s disease ; day:28 ; month:9 ; year:2022 ; pages:1-9
Journal of neurology ; (28.9.2022), 1-9

Creator
Periñán, María Teresa
Macías-García, Daniel
Jesús, Silvia
Martín-Rodríguez, Juan Francisco
Muñoz-Delgado, Laura
Jimenez-Jaraba, Maria Valle
Buiza-Rueda, Dolores
Bonilla-Toribio, Marta
Adarmes-Gómez, Astrid Daniela
Gómez-Garre, Pilar
Mir, Pablo
Contributor
SpringerLink (Online service)

DOI
10.1007/s00415-022-11361-y
URN
urn:nbn:de:101:1-2022121621003824477770
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:22 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Periñán, María Teresa
  • Macías-García, Daniel
  • Jesús, Silvia
  • Martín-Rodríguez, Juan Francisco
  • Muñoz-Delgado, Laura
  • Jimenez-Jaraba, Maria Valle
  • Buiza-Rueda, Dolores
  • Bonilla-Toribio, Marta
  • Adarmes-Gómez, Astrid Daniela
  • Gómez-Garre, Pilar
  • Mir, Pablo
  • SpringerLink (Online service)

Other Objects (12)

Mild Cognitive Impairment in Parkinson’s Disease—What Is It?

Mild Cognitive Impairment in Parkinson’s Disease—What Is It?

Advanced brain aging in Parkinson’s disease with cognitive impairment

Advanced brain aging in Parkinson’s disease with cognitive impairment

Resting-state EEG measures cognitive impairment in Parkinson’s disease

Resting-state EEG measures cognitive impairment in Parkinson’s disease

Mild cognitive impairment in Parkinson’s disease: a distinct clinical entity?

Mild cognitive impairment in Parkinson’s disease: a distinct clinical entity?

Paeoniflorin ameliorates cognitive impairment in Parkinson’s disease via JNK/p53 signaling

Paeoniflorin ameliorates cognitive impairment in Parkinson’s disease via JNK/p53 signaling

Misfolded protein deposits in Parkinson’s disease and Parkinson’s disease-related cognitive impairment, a [11C]PBB3 study

Misfolded protein deposits in Parkinson’s disease and Parkinson’s disease-related cognitive impairment, a [11C]PBB3 study

Theory of mind in mild cognitive impairment and Parkinson’s disease: The role of memory impairment

Theory of mind in mild cognitive impairment and Parkinson’s disease: The role of memory impairment

Gut microbiome is not associated with mild cognitive impairment in Parkinson’s disease

Gut microbiome is not associated with mild cognitive impairment in Parkinson’s disease

Metaproteogenomic analysis of saliva samples from Parkinson’s disease patients with cognitive impairment

Metaproteogenomic analysis of saliva samples from Parkinson’s disease patients with cognitive impairment

Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson’s disease

Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson’s disease

Cognitive reorganization in patients with Parkinson’s Disease and Mild Cognitive Impairment: a neuropsychological network approach

Cognitive reorganization in patients with Parkinson’s Disease and Mild Cognitive Impairment: a neuropsychological network approach

Altered regional homogeneity of prefrontal cortex in Parkinson’s disease with mild cognitive impairment

Altered regional homogeneity of prefrontal cortex in Parkinson’s disease with mild cognitive impairment

Related objects